# NCT01730937 (NCT01730937)

> Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01730937
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer
- Interventions: Sorafenib; stereotactic body radiation therapy
- Enrollment: 193
- Primary outcome: Overall Survival

## Commentary we found

- X threads: 103
- YouTube: 6
- Podcasts: 6
- X videos: 3

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct01730937

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01730937", "email": "<work email>"}; the inbox owner confirms by the emailed link.